| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536900 | Vaccine | 2017 | 9 Pages |
Abstract
The present review demonstrates that up to 78.4% of reported invasive pneumococcal disease in children â¤Â 5 years in India are currently caused by serotypes that are included in the available licensed PCVs. However, sentinel surveillance must be continued in representative parts of the country to assess the changing trends in distribution of pneumococcal serotypes and their implication for vaccine selection and rollout in India.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jyotsana Singh, Suba Sundaresan, Anand Manoharan, Anita Shet,